From bladder to kidney: calprotectin as a novel marker for differentiation of urinary tract infection
World Journal of Urology · 2025
DOI: 10.1007/s00345-025-06138-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, 2025. Verfasst von Fehmi Eryazıcı und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Dr. Halil İbrahim Özsoy Bolvadin State Hospital, Afyonkarahisar, Türkiye. fehmieryazici03@gmail.com. Hauptthemen laut MEDLINE: Leukocyte L1 Antigen Complex, Cystitis, Pyelonephritis, Urinary Tract Infections. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Necmettin Erbakan University - Scientific Research Projects Board.
Abstract (Originalsprache)
BACKGROUND: Urinary tract infections (UTIs) are common diseases in the community that can lead to significant morbidity and mortality. UTIs can be classified as cystitis or pyelonephritis based on their location. Calprotectin is a protein released from monocytes and neutrophils that plays a role in the inflammatory response and antimicrobial defense. In this study it was aimed to investigate the diagnostic potential of calprotectin in distinguishing acute cystitis from acute pyelonephritis by evaluating serum and urine calprotectin levels in patients with UTI. METHODS: The study included adults aged 18 years and older who were admitted to our clinic with UTIs, including both pyelonephritis and cystitis, as well as healthy volunteers who served as the control group, between January 2024 and October 2024. In addition to routine biochemical and hematological tests, serum and urine calprotectin levels were measured. Data were analyzed using SPSS 21.0. RESULTS: A total of 88 participants were included in the study: 30 patients with pyelonephritis, 30 patients with cystitis, and 28 healthy controls. Female gender was predominant in all groups. Serum calprotectin levels were higher in patients with pyelonephritis and cystitis compared to the healthy control group (p < 0.001). Urinary calprotectin levels were significantly higher in the cystitis group compared to the pyelonephritis and healthy controls (p < 0.001). There was a positive and significant correlation between serum calprotectin and C-reactive protein (CRP) and procalcitonin (PCT) levels. CONCLUSIONS: Our study suggests that calprotectin may be a useful biomarker in the diagnosis of UTI and the differentiation between lower and upper urinary tract infections, and sheds light on future large-scale studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Dr. Halil İbrahim Özsoy Bolvadin State Hospital, Afyonkarahisar, Türkiye. fehmieryazici03@gmail.com.
- Department of Infectious Diseases and Clinical Microbiology, Necmettin Erbakan University Faculty of Medicine, Konya, Türkiye.
Förderung
- Necmettin Erbakan University - Scientific Research Projects Board
Zitieren
APA
Eryazıcı, F., Kandemir, B., Bulut, R., & Erayman, İ. (2025). From bladder to kidney: calprotectin as a novel marker for differentiation of urinary tract infection. World Journal of Urology. https://doi.org/10.1007/s00345-025-06138-7
Vancouver
Eryazıcı F, Kandemir B, Bulut R, Erayman İ. From bladder to kidney: calprotectin as a novel marker for differentiation of urinary tract infection. World Journal of Urology. 2025. doi:10.1007/s00345-025-06138-7
BibTeX
@article{Eryazc2025,
author = {Eryazıcı, Fehmi and Kandemir, Bahar and Bulut, Rukiyye and Erayman, İbrahim},
title = {From bladder to kidney: calprotectin as a novel marker for differentiation of urinary tract infection},
journal = {World Journal of Urology},
year = {2025},
doi = {10.1007/s00345-025-06138-7}
}
EUVIMED